ADmit Therapeutics

About:

ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.

Website: http://www.admit-therapeutics.com/en

Twitter/X: ADmitTherapeut1

Top Investors: European Innovation Council, Alzheimer's Drug Discovery Foundation, Ship2B, Clave Capital, WA4STEAM

Description:

ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with an easy way to detect early-stage Alzheimer.